The COVID-19 pandemic resulted in the proliferation of new data that have created unprecedented opportunities to establish early warning systems for pandemics. These systems not only have capabilities to predict and detect pathogens that...

Clinical trial enrollment can vary based on demographics. Cancer drug trials, for example, have been shown to skew disproportionately toward young, White, male participants. Variability also exists in a treatment’s effectiveness across...

Overview On July 27, 2023, Senators Lindsey Graham (R-SC) and Elizabeth Warren (D-MA) unveiled the Digital Consumer Protection Commission Act (DCPC), a bill proposing to establish a new commission responsible for enforcing newfound...

Overview Global powers are moving to regulate artificial intelligence (AI), with China and Europe making the first moves. US regulators and AI industry leaders have been working on a regulatory framework for the US over the last few months...

Overview On January 30, 2023, Twitter began applying for regulatory licenses to offer financial services. A payments model such as the one Twitter is pursuing would be in the same competitive space as Venmo, Cash App, Zelle, and other Big...

Overview As Big Tech companies face continued scrutiny over their handling of personal health information, the limitations of US health privacy regulation in a digital age are becoming more evident. Policymakers, both in the US and around...

We live in an insights economy fueled by powerful data. Business leaders and the companies they run have dedicated considerable time, resources, and talent to think through new ways of leveraging that data to power better decision-making...

Large tech companies and their customer-centric business models have led to gains in efficiency that have benefitted consumers and businesses worldwide. At the same time, the cross-sectoral nature of these companies exposes the world to new...

Washington, D.C. – Dec. 2, 2020 – FasterCures, a center of the Milken Institute devoted to accelerating biomedical innovation, today launched an initiative to build a global “early warning system” that detects and responds to emerging...

In a webinar on September 23, 2020, FasterCures brought together Peter Marks, director of the US Food and Drug Administration's (FDA) Center for Biologics Evaluation and Research, Gwen Nichols, chief medical officer of the Leukemia &...